These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 25644809
1. Corosolic Acid Exhibits Anti-angiogenic and Anti-lymphangiogenic Effects on In Vitro Endothelial Cells and on an In Vivo CT-26 Colon Carcinoma Animal Model. Yoo KH, Park JH, Lee DY, Hwang-Bo J, Baek NI, Chung IS. Phytother Res; 2015 May; 29(5):714-23. PubMed ID: 25644809 [Abstract] [Full Text] [Related]
2. 3-O-Acetyloleanolic acid inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis via suppression of angiopoietin-1/Tie-2 signaling. Hwang-Bo J, Park JH, Chung IS. Phytother Res; 2020 Feb; 34(2):359-367. PubMed ID: 31680342 [Abstract] [Full Text] [Related]
3. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis. Hwang-Bo J, Yoo KH, Park JH, Jeong HS, Chung IS. Int J Cancer; 2012 Jul 15; 131(2):298-309. PubMed ID: 21823121 [Abstract] [Full Text] [Related]
4. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model. Hwang-Bo J, Bae MG, Park JH, Chung IS. BMC Cancer; 2018 Jul 05; 18(1):714. PubMed ID: 29976150 [Abstract] [Full Text] [Related]
5. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases. García-Caballero M, Paupert J, Blacher S, Van de Velde M, Quesada AR, Medina MA, Noël A. J Hematol Oncol; 2017 Jun 19; 10(1):122. PubMed ID: 28629427 [Abstract] [Full Text] [Related]
6. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling. Liu Y, He Y, Yang F, Cong X, Wang J, Peng S, Gao D, Wang W, Lan L, Ying X, Liu M, Chen Y, Yi Z. Sci China Life Sci; 2017 Feb 19; 60(2):202-214. PubMed ID: 28194552 [Abstract] [Full Text] [Related]
7. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling. Chen HM, Tsai CH, Hung WC. Oncotarget; 2015 Jun 20; 6(17):14940-52. PubMed ID: 25909285 [Abstract] [Full Text] [Related]
8. Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth. Lai KC, Hsu SC, Yang JS, Yu CC, Lein JC, Chung JG. J Cell Mol Med; 2015 Feb 20; 19(2):474-84. PubMed ID: 25403643 [Abstract] [Full Text] [Related]
9. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis. Bi YL, Mi PY, Zhao SJ, Pan HM, Li HJ, Liu F, Shao LR, Zhang HF, Zhang P, Jiang SL. Int J Mol Med; 2017 May 20; 39(5):1255-1261. PubMed ID: 28358414 [Abstract] [Full Text] [Related]
13. Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats. Thiele W, Rothley M, Teller N, Jung N, Bulat B, Plaumann D, Vanderheiden S, Schmaus A, Cremers N, Göppert B, Dimmler A, Eschbach V, Quagliata L, Thaler S, Marko D, Bräse S, Sleeman JP. Carcinogenesis; 2013 Dec 20; 34(12):2804-13. PubMed ID: 23975834 [Abstract] [Full Text] [Related]
16. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer. Hong SW, Jung KH, Park BH, Zheng HM, Lee HS, Choi MJ, Yun JI, Kang NS, Lee J, Hong SS. Cancer Lett; 2013 May 10; 332(1):74-82. PubMed ID: 23348694 [Abstract] [Full Text] [Related]
18. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways. Lin J, Chen Y, Wei L, Hong Z, Sferra TJ, Peng J. Int J Oncol; 2013 Nov 10; 43(5):1666-74. PubMed ID: 24042330 [Abstract] [Full Text] [Related]